Aerie Pharmaceuticals (AERI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2011 | 12-2006 | 12-2005 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 15,068 | N/A | N/A |
| TOTAL | $15,201 | $N/A | $N/A |
| Non-Current Assets | |||
| PPE Net | 220 | N/A | N/A |
| Other Non-Current Assets | 37 | 0 | 0 |
| TOTAL | $257 | $N/A | $N/A |
| Total Assets | $15,458 | $N/A | $N/A |
| Liabilities | |||
| Current Liabilities | |||
| Accounts payable and accrued liabilities | 2,709 | 0 | 0 |
| TOTAL | $2,709 | $N/A | $N/A |
| Non-Current Liabilities | |||
| Other Non-Current Liabilities | 1,098 | 0 | 0 |
| TOTAL | $1,098 | $N/A | $N/A |
| Total Liabilities | $3,807 | $N/A | $N/A |
| Shareholders' Equity | |||
| Common Shares | 5 | N/A | N/A |
| Retained earnings | -48,810 | N/A | N/A |
| Other shareholders' equity | 60,348 | 0 | 0 |
| TOTAL | $11,651 | $N/A | $N/A |
| Total Liabilities And Equity | $15,458 | $0 | $0 |